BIOtechNOW: International AIDS Conference Unveils Four New “Next Generation” Treatments for HIV

New data presented at the 2010 International AIDS Conference showed significant momentum for the emerging fields of therapeutic vaccines, anti-immune hyperactivation, and other immune based therapies for the treatment of HIV/AIDS. New data presented by researchers at the XVIII International AIDS Conference on Thursday, July 22 showed significant momentum for the emerging field of therapeutic vaccines, anti-immune …

Read more

Successful therapeutic vaccination with Vacc-4x

Successful therapeutic vaccination of HIV patients with Vacc-4x, Bionor Pharma’s peptide-based therapeutic vaccine for HIV-1 infection Bionor Pharma announced today presentation of data from its international multicenter double-blinded placebo-controlled phase IIB study at the IAS conference in Rome. As previously communicated, a statistically significant difference in viral load set point was observed between the Vacc-4x …

Read more

Vacc-4x phase IIB study accepted as a poster at the IAS conference

Oslo, 21.06.2011 – An abstract of Bionor Pharma’s Vacc-4x phase IIB study has been accepted as poster at the IAS conference in Rome 17-20 July 2011. Bionor Pharma has been informed that an abstract of the Vacc-4x phase IIB study has been accepted to be presented as a poster at the 6(th) IAS Conference on …

Read more